Are you Dr. Dreisbach?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 89 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
39800 Bob Hope Dr
Ste C
Rancho Mirage, CA 92270Phone+1 760-568-3613Fax+1 760-340-5189- Is this information wrong?
Summary
- Dr. Luke Dreisbach, MD is an oncologist in Rancho Mirage, California. He is currently licensed to practice medicine in California, Wisconsin, and Arizona. He is affiliated with Eisenhower Health.
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1998 - 2001- University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 1994 - 1997
McGovern Medical School at UTHealthClass of 1994
Certifications & Licensure
AZ State Medical License 1996 - Present
CA State Medical License 2000 - 2025
WI State Medical License 1997 - 1999- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:San Diego Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia Start of enrollment: 2009 Oct 19
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Start of enrollment: 2010 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 65 citationsContinuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trialAlain Algazi, Megan Othus, Adil Daud, Roger S. Lo, Janice M. Mehnert, Thach Giao Truong, Robert M. Conry, Kari Kendra, Gary C. Doolittle, Joseph I. Clark, Michael J. M...> ;Nature Medicine. 2020 Oct 5
- 49 citationsFinal results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia.Clemens M. Wendtner, Peter Hillmen, Daruka Mahadevan, Andreas Bhler, Lutz Uharek, Steven Coutre, Olga Frankfurt, Adrian Bloor, Francesc Bosch, Richard R. Furman, Eva K...> ;Leukemia & Lymphoma. 2012 Mar 1
- 2 citationsPhase I study of fixed dose gemcitabine plus epirubicin in patients with advanced solid malignancies.Daruka Mahadevan, Luke Dreisbach, Timothy Kristedja, Debbie Williams, Yrma Obregon, Sandy Kurtin, Daniel D. Von Hoff> ;American Journal of Clinical Oncology. 2009 Dec 1
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Eisenhower HealthRancho Mirage, California
